Toll-like receptor kinetics in septic shock patients: a preliminary study.
The aim of this study is to evaluate some inflammatory parameter changes in septic shock patients and their possible correlation with clinical outcome, in particular when continuous veno-venous hemofiltration (CVVH) treatment is required. Considering the objective difficulty in enrolling this kind of patient, a preliminary study was initiated on seventeen septic shock patients admitted to a medical and surgical ICU. The mRNA expression of Toll-like receptor (TLR)-1, TLR-2, TLR-4, TLR-5, TLR-9, TNFα, IL-8 and IL-1β was assessed, the plasmatic concentrations of IL-18, IL-2, IL-10 and TNFα were measured on the day of sepsis diagnosis and after 72 h. In those patients who developed acute renal failure unresponsive to medical treatment and who underwent CVVH treatment the same parameters were measured every 24 h during CVVH and after completion of the treatment. On sepsis diagnosis, gene expression of TLRs was up-regulated compared to the housekeeping gene in all the patients. After 72 h, in 35% of the patients a down-regulation of these genes was found compared to day 1, but it was not associated with a reduction of cytokine serum levels or improved clinical signs, better outcome or reduced mortality. After high volume hemofiltration treatment, cytokine serum levels and TLR expression were not significantly modified. In conclusion, considering the not numerous number of cases, from our preliminary study, we cannot certainly correlate TLR over-expression in septic shock patients with severity or outcome scores.
Department of Medicine and Surgery, University of Salerno, Italy.
O
O
Piazza
G
G
Pulcrano
P L
PL
Fiori
R
R
Tufano
M
M
Lonardo
F
F
Rossano
M R
MR
Catania
D058186:Acute Kidney Injury / Q000276:immunology / Q000628:therapy; D000293:Adolescent; D000368:Aged; D000369:Aged, 80 and over; D016207:Cytokines / Q000097:blood; D005260:Female; D005786:Gene Expression Regulation; D006440:Hemofiltration; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood; D007362:Intensive Care Units; D007558:Italy; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D012333:RNA, Messenger / Q000097:blood; D012720:Severity of Illness Index; D012772:Shock, Septic / Q000175:diagnosis / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D051193:Toll-Like Receptors / Q000097:blood* / Q000235:genetics; D055815:Young Adult
D016207:Cytokines; D018836:Inflammation Mediators; D012333:RNA, Messenger; D051193:Toll-Like Receptors